Precision for Medicine
Harpreet Singh, MDChief Medical Officer
Harpreet Singh, MD, is Chief Medical Officer at Precision for Medicine, where she provides medical and scientific leadership for biomarker-driven clinical development across oncology and rare diseases. Prior to joining Precision, Dr. Singh served in senior leadership roles at the U.S. Food and Drug Administration, most recently as Director of the Division of Oncology, overseeing the regulatory review of drugs and biologics for a broad range of solid and rare tumors. A medical oncologist by training, she is widely recognized for her leadership in precision medicine, innovative clinical trial design, and regulatory science, including spearheading FDA initiatives to streamline and modernize oncology trials. Dr. Singh completed her medical training at the Keck School of Medicine of the University of Southern California and was a fellow at the National Cancer Institute.
Insights from Harpreet Singh, MD
Research & Development | White Paper
Moving ADCs to the front-line: Perspectives from FDA Oncology Experts
Research & Development | White Paper
Advancing Radiopharmaceuticals From Regulatory Approval to Global Access
Research & Development | White Paper
Navigating Global Regulations for Radiopharmaceutical Development